Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Legal & General Increases Vectura Stake To 3.7% From Below 3% (ALLISS)

Tue, 20th Mar 2018 13:21

LONDON (Alliance News) - Vectura Group PLC said Tuesday FTSE 100-listed insurer and asset manager Legal & General Group PLC increased its stake in the pharmaceutical firm to 3.7% from below 3% in a transaction last Friday.

Legal & General held 24.8 million shares in Vectura after the transaction, equivalent to a 3.7% stake in the 663.8 million shares outstanding. Prior to the transaction, Legal & General's holding was below the 3% notifiable threshold.

Shares in Vectura were 1.1% higher at 79.55 pence on Tuesday.

More News
10 Jun 2016 11:06

LONDON MARKET MIDDAY: Risk-Off Mood Hits Stocks As Bond Yields Shrink

Read more
10 Jun 2016 09:50

WINNERS & LOSERS SUMMARY: Vectura Shares Rise After Skyepharma Tie Up

Read more
10 Jun 2016 07:41

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

Read more
10 Jun 2016 06:56

Vectura-Skyepharma Merger Completed As Scheme Becomes Effective (ALLISS)

Read more
3 Jun 2016 06:17

Vectura Says VR942 Asthma Treatment Phase-One Trials Meet Objective

Read more
26 May 2016 09:47

Vectura reports strong rise in full-year earnings

(ShareCast News) - Vectura´s full-year results edged past forecasts with analysts noting the sharp improvement in its free-cash-flow generation even as they pointed out several potential share price drivers which were looming increasingly closer on the horizon. The manufacturer of airways diseases t

Read more
26 May 2016 06:56

Vectura Sees Narrowed Loss Ahead Of Skyepharma Deal Completion

Read more
24 May 2016 09:30

Vectura teams up with Propeller on inhaler plan

(ShareCast News) - Vectura Group said it was joining forces with Propeller Health to develop inhalers that combine their two technologies. In a statement, Vectura said the plan was to use its dry powder inhaler technology with Propeller's FDA-cleared digital health platform to treat respiratory dise

Read more
24 May 2016 06:49

Vectura Teams Up With Propeller Health To Combine Technology

Read more
20 May 2016 06:29

Vectura Says Skyepharma Deal To Complete By June 10

Read more
19 May 2016 15:06

Earnings, Trading Statements Calendar - Week Ahead

Read more
18 May 2016 07:24

Skyepharma Says Trading Good, Anticipates Full-Year Revenue Growth

Read more
16 May 2016 16:13

Vectura, Skyepharma Merger Cleared By UK Competition Authority

Read more
3 May 2016 14:21

Drug trials using Vectura's Fox nebuliser make progress

(ShareCast News) - A respiratory treatment being developed using Vectura's Fox nebuliser technology device has passed safety and efficacy trials and looks likely to be moved into a Phase II efficacy study in infants. Drug developer Ablynx has published positive results from first-in-infant Phase I/I

Read more
28 Apr 2016 15:00

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.